Nautilus Biotechnology Inc.

Special purpose acquisition corporations did not have a very successful run in the last SPAC wave to hit the life science sector, but a new round of the vehicles that provide companies an alternative

The University of Texas MD Anderson Cancer Center and US/UK biotech Replay announced on 14 February that they are launching a new company, Syena, to advance research conducted at the cancer center o

1. Miserable Year For Major M&A M&A activity in 2020 was pretty quiet but positively ear-splitting compared to the first half of 2021. The lack of deals was due in no small part to the US Federal Trad

Amicus Therapeutics, Inc. is spinning out its rare disease gene therapy portfolio into a separate publicly traded company and using the increasingly popular special purpose acquisition corporation (S